Cargando…

Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice

BACKGROUND: NEO212 is a novel small-molecule anticancer agent that was generated by covalent conjugation of the natural monoterpene perillyl alcohol (POH) to the alkylating agent temozolomide (TMZ). It is undergoing preclinical development as a therapeutic for brain-localized malignancies. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Hee-Yeon, Swenson, Steve, Thein, Thu Zan, Wang, Weijun, Wijeratne, Neloni R, Marín-Ramos, Nagore I, Katz, Jonathan E, Hofman, Florence M, Schönthal, Axel H, Chen, Thomas C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Basic and Translational Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764505/ https://www.ncbi.nlm.nih.gov/pubmed/33392507 http://dx.doi.org/10.1093/noajnl/vdaa160

Ejemplares similares

NEO212, a Perillyl Alcohol-Temozolomide Conjugate, Triggers Macrophage Differentiation of Acute Myeloid Leukemia Cells and Blocks Their Tumorigenicity
por: Chen, Thomas C., et al.
Publicado: (2022)

Cytotoxic impact of a perillyl alcohol–temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro
por: Silva-Hirschberg, Catalina, et al.
Publicado: (2019)

Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia
por: Schönthal, Axel H., et al.
Publicado: (2021)

Induction of Pro-Apoptotic Endoplasmic Reticulum Stress in Multiple Myeloma Cells by NEO214, Perillyl Alcohol Conjugated to Rolipram
por: Chen, Thomas C., et al.
Publicado: (2018)

NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo
por: Swenson, Steve, et al.
Publicado: (2018)

NEO212: sub-cytotoxic doses capable of inhibiting glioma stem cell invasion
por: Marín-Ramos, Nagore I., et al.
Publicado: (2018)

Detection of perillyl alcohol and its metabolite perillic acid in postsurgical glioblastoma tissue after intranasal administration of NEO100: illustrative case
por: Schönthal, Axel H., et al.
Publicado: (2022)

Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases
por: Chen, Thomas C., et al.
Publicado: (2016)

Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma
por: Schönthal, Axel H, et al.
Publicado: (2021)

Temozolomide-perillyl alcohol conjugate induced reactive oxygen species accumulation contributes to its cytotoxicity against non-small cell lung cancer
por: Song, Xingguo, et al.
Publicado: (2016)

Temozolomide-Perillyl alcohol conjugate impairs Mitophagy flux by inducing lysosomal dysfunction in non-small cell lung Cancer cells and sensitizes them to irradiation
por: Chang, Minghui, et al.
Publicado: (2018)

Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development
por: Chen, Thomas C., et al.
Publicado: (2018)

On optimal temozolomide scheduling for slowly growing glioblastomas
por: Segura-Collar, Berta, et al.
Publicado: (2022)

Intranasal Delivery of miR133b in a NEO100-Based Formulation Induces a Healing Response in Spinal Cord-Injured Mice
por: Danilov, Camelia A., et al.
Publicado: (2023)

The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers
por: Chen, Thomas C., et al.
Publicado: (2021)

Cannabidiol inhibits RAD51 and sensitizes glioblastoma to temozolomide in multiple orthotopic tumor models
por: Soroceanu, Liliana, et al.
Publicado: (2022)

Detection of temozolomide-induced hypermutation and response to PD-1 checkpoint inhibitor in recurrent glioblastoma
por: Daniel, Paul, et al.
Publicado: (2022)

EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand
por: Hoogstrate, Youri, et al.
Publicado: (2019)

NEO212 induces mitochondrial apoptosis and impairs autophagy flux in ovarian cancer
por: Song, Xingguo, et al.
Publicado: (2019)

Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas
por: Minea, Radu O., et al.
Publicado: (2020)

TGF-β1 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT
por: Nie, Er, et al.
Publicado: (2020)

XAF1 directs glioma response to temozolomide through apoptotic transition of autophagy by activation of ATM–AMPK signaling
por: Lee, Min-Goo, et al.
Publicado: (2022)

Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivo
por: Chen, Thomas C., et al.
Publicado: (2015)

PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O(6)-methylguanine DNA damage in glioblastoma
por: Wu, Shaofang, et al.
Publicado: (2021)

Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis
por: Batara, Julette Marie F, et al.
Publicado: (2022)

Perillyl alcohol: Dynamic interactions with the lipid bilayer and implications for long-term inhalational chemotherapy for gliomas
por: da Fonseca, Clovis Orlando, et al.
Publicado: (2016)

Temozolomide–perillyl alcohol conjugate downregulates O(6)-methylguanin DNA methltransferase via inducing ubiquitination-dependent proteolysis in non-small cell lung cancer
por: Song, Xingguo, et al.
Publicado: (2018)

EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1–2 signaling
por: Wei, Yutian, et al.
Publicado: (2020)

Tumor volumes as a predictor of response to the anti-EGFR antibody drug conjugate depatuxizumab mafadotin
por: Gan, Hui K, et al.
Publicado: (2021)

Adjuvant effect of low-carbohydrate diet on outcomes of patients with recurrent glioblastoma under intranasal perillyl alcohol therapy
por: Santos, Juliana Guimaraes, et al.
Publicado: (2020)

DDRE-06. REGULATION OF TUMOR MICROENVIRONMENT VIA ENDOTHELIAL-TO-MESENCHYMAL TRANSITION BLOCKADE IN GLIOBLASTOMA-ASSOCIATED BRAIN ENDOTHELIAL CELLS
por: Marin’ Ramos, Nagore I, et al.
Publicado: (2021)

Perillyl Alcohol Protects Against Fe-NTA-Induced Nephrotoxicity and Early Tumor Promotional Events in Rat Experimental Model
por: Jahangir, Tamanna, et al.
Publicado: (2007)

Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts
por: Porath, Kendra A, et al.
Publicado: (2022)

(212)Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint
por: Yong, K J, et al.
Publicado: (2013)

Temozolomide induces senescence but not apoptosis in human melanoma cells
por: Mhaidat, N M, et al.
Publicado: (2007)

Monitoring response to a clinically relevant IDH inhibitor in glioma—Hyperpolarized (13)C magnetic resonance spectroscopy approaches
por: Hong, Donghyun, et al.
Publicado: (2023)

Poly‐γ‐S‐perillyl‐l‐glutamate and Poly‐γ‐S‐perillyl‐d‐glutamate: Diastereomeric Alignment Media Used for the Investigation of the Alignment Process
por: Alcaraz Janßen, Marcel, et al.
Publicado: (2020)

Combination of temozolomide with immunocytokine F16–IL2 for the treatment of glioblastoma
por: Pedretti, M, et al.
Publicado: (2010)

Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma
por: Wang, Zihao, et al.
Publicado: (2023)

GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data
por: Ajaib, Shoaib, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4b3m580q66n5qmf00mpu74pqhl